Navigation Links
Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc.
Date:4/27/2015

NEW YORK, April 27, 2015 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: AERI), concerning whether the board has breached its fiduciary duties to shareholders.

On April 24, 2015, the Company issued a press release announcing results from its first Phase 3 registration trial of Rhopressa.  Among other things, the press release disclosed that in the trial, Rhopressa failed to meet its primary efficacy endpoint in connection with its ability to lower intraocular pressure. 

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.

If you own Aerie shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email:  bsachsmichaels@hfesq.com
Website:   http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm. 

The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

 


'/>"/>
SOURCE Harwood Feffer LLP
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Harwood Feffer LLP Announces Investigation of OvaScience, Inc.
2. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
3. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
4. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
5. Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.
6. Harwood Feffer LLP Announces Investigation of Avanir Pharmaceuticals, Inc.
7. Harwood Feffer LLP Announces Investigation of Advaxis, Inc.
8. Harwood Feffer LLP Announces Investigation of Acadia Pharmaceuticals Inc.
9. Harwood Feffer LLP Announces Investigation of Dietary Supplements Containing BMPEA
10. Pharmagen Announces First Quarter 2013 Results
11. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... ... the launch of RegistryConnect , the first and most compliant online management ... includes care-matching, schedule recording, client and caregiver relationship management. RegistryConnect is available only ...
(Date:9/17/2019)... ... September 17, 2019 , ... For the 6th year in a row, Mental ... ranks all 50 states and the District of Columbia based on several mental health and ... The report also takes a look back on the trends of the last 6 years ...
(Date:9/17/2019)... ... September 17, 2019 , ... Embr Labs , the breakthrough thermal technology ... led by DigiTx Partners, with participation from Safar Partners, Joyance Partners ... to grow the company’s footprint in wellness and digital therapeutics, accelerate development for the ...
Breaking Medicine Technology:
(Date:9/17/2019)... SARASOTA, Fla. (PRWEB) , ... September 17, 2019 ... ... plans and Dental Service Organizations (DSOs) has earned Michael Cole, Vice President of ... presented today by the National Association of Dental Plans (NADP) at their annual ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... join the largest accountable care organization (ACO) in the country, the company announced ... groundbreaking collaboration to improve care quality and increase cost efficiency. This opportunity is ...
(Date:9/17/2019)... ... September 17, 2019 , ... Genomenon ... , with the goal of providing resources to assist researchers and encourage pharmaceutical ... progressive disease causing abnormal iron deposits in the brain. , BPAN Warriors ...
(Date:9/14/2019)... Okla. (PRWEB) , ... September 14, 2019 , ... ... cannabis industry, has time and again tried to bring the most relevant and important ... ray of hope on an increasingly large number of people across the world suffering ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global Education Group (Global), ... (CME) provider, is the official accreditor for PAINWeek, the largest US pain conference ... topics, as it has done for the past ten years. In addition, the ...
Breaking Medicine News(10 mins):